Targeted Medical Pharma to Present at 6th Annual LD Micro Growth Conference

LD MICRO 2013

LOS ANGELES--()--Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the LD Micro Growth Conference on December 5, 2012 at 1:30 p.m. Pacific Time. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc., is a Los Angeles-based biotechnology company that develops medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary medical foods, and recently launched its first dietary supplement, Clearwayz™. The products are sold directly to physicians and pharmacies in the U.S. The company also is developing nutrient-based systems for autistic spectrum disorders and for the oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I.

Contacts

Media:
Targeted Medical Pharma
Marcus Charuvastra, 310-474-9809
marcusch@tmedpharma.com
or
Investors:
ProActive Capital Group
Jeff Ramson, 646-863-6893
ramson@proactivecapital.com

Release Summary

Targeted Medical Pharma to present latest medical food sector advancements at LD Micro Conference in Los Angeles, CA.

Sharing

Contacts

Media:
Targeted Medical Pharma
Marcus Charuvastra, 310-474-9809
marcusch@tmedpharma.com
or
Investors:
ProActive Capital Group
Jeff Ramson, 646-863-6893
ramson@proactivecapital.com